Literature DB >> 27314538

Melanogenesis and DNA damage following photodynamic therapy in melanoma with two meso-substituted porphyrins.

Ioana Baldea1, Diana Elena Olteanu2, Pompei Bolfa3, Flaviu Tabaran4, Rodica-Mariana Ion5, Gabriela Adriana Filip6.   

Abstract

Melanoma, a cancer derived from melanocytes is very difficult to treat, especially in advanced cases. There are several encouraging studies of the efficacy of photodynamic therapy (PDT) in melanoma. However, PDT has to overcome the main defense mechanisms like: defects in the apoptotic pathways, pigmentation, sequestration of the photosensitisers (PS) inside melanosomes and increased oxidative stress defense. Two meso-substituted porphyrins, meso-5,10,15,20-tetrakis (4-hydroxyphenyl) porphyrin (THOPP) and meso-5-(4-hydroxyphenyl)-10, 15, 20-tris (4-methoxyphenyl) porphyrin (THOMPP) were used as PS to investigate several mechanisms underlining the PDT anti-melanoma effects, on a lightly pigmented melanoma cell line (WM35), in vitro. γH2AX foci formation (a measure of DNA double strand brakes) was used for the assessment of DNA damage by means of immune-fluorescence and western blot. Cytoskeleton alterations were detected by phalloidin staining. Tyrosinase activity and melanin pigment were quantified by spectrophotometry, tyrosinase protein by western blot, total peroxidase activity by resorurfin reaction (Amplex Red). PDT induced high levels of DNA damage, cytoskeleton alterations and enhanced pigmentogenesis. THOPP mediated PDT was the most efficient. The melanogenesis stimulated by PDT was directly correlated to the PDT induced cellular damage and provided no protection against therapy. Thus, PDT induced melanogenesis combined with severe DNA damage was able to overcome the mechanisms of resistance and increased the efficiency of PDT in WM35 melanoma cells. These results are encouraging for a possible use of PDT, as an adjuvant therapy in lightly pigmented melanomas.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Melanogenesis; Melanoma; Meso-substituted porphyrins; Photodynamic therapy; γH2AX

Mesh:

Substances:

Year:  2016        PMID: 27314538     DOI: 10.1016/j.jphotobiol.2016.06.012

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  3 in total

1.  Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy.

Authors:  Diana Tudor; Iuliana Nenu; Gabriela Adriana Filip; Diana Olteanu; Mihai Cenariu; Flaviu Tabaran; Rodica Mariana Ion; Lucian Gligor; Ioana Baldea
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

2.  Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.

Authors:  Yong Tao; Yunsheng Ou; Hang Yin; Yanyang Chen; Shenxi Zhong; Yongjian Gao; Zenghui Zhao; Bin He; Qiu Huang; Qianxing Deng
Journal:  Int J Oncol       Date:  2017-09-27       Impact factor: 5.650

3.  New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy.

Authors:  Zongjunlin Liu; Fang Xie; Jun Xie; Jianhao Chen; Yang Li; Qin Lin; Fanghong Luo; Jianghua Yan
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.